The Real Cost Case for Pharmaceutical Contract Manufacturing (2026)

The honest reason most pharmaceutical brands in India do not own a factory is arithmetic. A compliant plant costs crores before it makes a single tablet, and it earns nothing until it is validated, licensed and running near capacity. Contract manufacturing removes that maths from your business entirely.

This page is about the money. If you want the process instead — the steps, the documents, the timelines — read how third-party manufacturing actually works.

What you are actually not paying for

The plant

Land, building, clean rooms, HVAC, water systems, machinery, validation. A WHO-GMP compliant facility runs into tens of crores. Vibcare Healthcare's own plant carries 100,000 sq ft of clean room area — that is what the number looks like in practice, and it is capital you never have to raise.

The idle capacity

This is the cost nobody mentions. A plant that runs at 30% is losing money on 70% of its overheads. When you contract manufacture, you rent the batch, not the building — you pay for what you produce, and someone else carries the empty hours.

The compliance function

A licensed plant needs qualified persons, a QC lab, stability chambers, documentation systems and inspection readiness every day of the year, whether you sell anything or not. That team is a permanent fixed cost. Under a contract arrangement, it belongs to the manufacturer.

The dead capital in dosage forms you barely sell

Beta-lactam antibiotics legally require physically segregated premises. Ophthalmics and injectables need sterile lines. If you own one plant and want to sell across categories, you either build several facilities or you outsource anyway. Almost everyone outsources.

Where the money actually goes instead

Into stock you can sell and the market you sell it in. That is the whole argument. A brand owner with no plant puts capital into inventory, doctors and distribution — the parts that generate revenue — instead of into fixed assets that only cost.

It is also why third-party manufacturing suits a business with an uncertain forecast. Batch sizes flex. A plant does not.

The cost you should watch instead

Not the per-unit rate. The minimum order quantity. A cheap rate against a batch size you cannot sell in a year is not cheap — it is dead stock with a good price on it. Ask for the MOQ before you ask for the rate.

And the rate itself moves with composition, order quantity, packing, and whether you supply packing material. Two quotes are only comparable if all four match.

Who manufactures for Vibcare

Vibcare Pharma is a PCD pharma franchise company. It does not manufacture. Manufacturing is done by Vibcare Healthcare Private Limited — a separate company under the same ownership, with its own plant, licences and website.

Vibcare Healthcare's WHO-GMP certified plant is at Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024; licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. Certified for four dosage forms: tablets, capsules and external preparations (all non beta-lactam), and oral liquids. It does not make beta-lactams, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays or ayurvedic products, because it is not certified for them.

Not building your own brand? A PCD pharma franchise needs no manufacturing at all — you sell an existing range in a monopoly territory, starting from ₹25,000. Here is the difference.

Frequently asked questions

Is contract manufacturing cheaper than building your own plant?

For almost every brand owner, yes. A WHO-GMP compliant facility costs crores in capital plus a permanent compliance and QC team, and it only pays back near full capacity. Contract manufacturing converts that fixed cost into a per-batch cost, so capital goes into saleable stock and market building instead of fixed assets.

What affects third-party manufacturing cost in pharma?

Composition, order quantity, packing specification, and whether you supply the packing material. Two quotations are only comparable if all four match. The minimum order quantity matters more than the per-unit rate — a low rate against a batch you cannot sell within its shelf life is dead stock with a good price on it.

Why do pharma companies outsource manufacturing?

Capital, capacity and category coverage. A plant costs crores and loses money when idle. Different dosage forms legally require different premises — beta-lactams need segregated facilities, injectables and ophthalmics need sterile lines. Owning every category means building several plants, so most companies outsource at least part of their range.